Literature DB >> 27868476

Latent structure of cognitive performance in the adult children study.

Denise Head1,2,3, Samantha Allison1, Nathaniel Lucena1, Jason Hassenstab1,2,4, John C Morris2,4.   

Abstract

OBJECTIVE: The Adult Children Study (ACS) at the Knight Alzheimer's Disease Research Center is a longitudinal investigation designed to identify and validate potential biomarkers of preclinical Alzheimer's disease (AD) in cognitively normal individuals with and without a family history of AD. The purpose of the current study was to validate the proposed latent structure of the ACS psychometric battery.
METHOD: Confirmatory factor analyses of baseline data in a sample of 229 (75 men) cognitively normal middle-aged to older adult individuals assessed a hypothesized 4-factor model of cognitive performance. Measurement invariance was investigated as a function of family history of AD and apolipoprotein E (APOE) status.
RESULTS: This study confirmed a priori hypotheses of 4 latent cognitive domains in a unique longitudinal sample of cognitively normal adults. In addition, there was evidence of a similar factor structure for family history and APOE status groups.
CONCLUSION: These robust indicators of a broad range of cognitive domains will be used in future investigations to track the influence of family history of AD on cognitive performance over time. In addition, associations with fluid, structural, and molecular biomarkers of preclinical AD will be further examined, both cross-sectionally and longitudinally in this sample.

Entities:  

Keywords:  Cognitive aging; Confirmatory factor analysis; Measurement invariance; Psychometric test battery

Mesh:

Substances:

Year:  2016        PMID: 27868476      PMCID: PMC5438781          DOI: 10.1080/13803395.2016.1252725

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  45 in total

1.  Short-term retention of individual verbal items.

Authors:  L R PETERSON; M J PETERSON
Journal:  J Exp Psychol       Date:  1959-09

Review 2.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

3.  Screening for dementia by memory testing.

Authors:  E Grober; H Buschke; H Crystal; S Bang; R Dresner
Journal:  Neurology       Date:  1988-06       Impact factor: 9.910

4.  Alzheimer disease biomarkers, attentional control, and semantic memory retrieval: Synergistic and mediational effects of biomarkers on a sensitive cognitive measure in non-demented older adults.

Authors:  Andrew J Aschenbrenner; David A Balota; Chi-Shing Tse; Anne M Fagan; David M Holtzman; Tammie L S Benzinger; John C Morris
Journal:  Neuropsychology       Date:  2014-09-15       Impact factor: 3.295

5.  Diagnosis of Alzheimer's disease using neuropsychological testing improved by multivariate analyses.

Authors:  Robert M Chapman; Mark Mapstone; Anton P Porsteinsson; Margaret N Gardner; John W McCrary; Elizabeth DeGrush; Lindsey A Reilly; Tiffany C Sandoval; Maria D Guillily
Journal:  J Clin Exp Neuropsychol       Date:  2010-10       Impact factor: 2.475

6.  An evaluation of the NINCDS-ADRDA neuropsychological criteria for the assessment of Alzheimer's disease: a confirmatory factor analysis of single versus multi-factor models.

Authors:  D A Loewenstein; R Ownby; L Schram; A Acevedo; M Rubert; T Argüelles
Journal:  J Clin Exp Neuropsychol       Date:  2001-06       Impact factor: 2.475

7.  The utility of Stroop task switching as a marker for early-stage Alzheimer's disease.

Authors:  Keith A Hutchison; David A Balota; Janet M Duchek; Janet M Ducheck
Journal:  Psychol Aging       Date:  2010-09

8.  Apolipoprotein E and cognitive performance: a meta-analysis.

Authors:  Brent J Small; Christopher B Rosnick; Laura Fratiglioni; Lars Bäckman
Journal:  Psychol Aging       Date:  2004-12

9.  The myth of testing construct validity using factor analysis or correlations with normal or mixed clinical populations: lessons from memory assessment.

Authors:  Dean C Delis; Mark Jacobson; Mark W Bondi; Joanne M Hamilton; David P Salmon
Journal:  J Int Neuropsychol Soc       Date:  2003-09       Impact factor: 2.892

10.  Assessing the cognitive abilities that differentiate patients with Alzheimer's disease from normals: single and multiple factor models.

Authors:  Raymond L Ownby; David A Loewenstein; Lynn Schram; Amarilis Acevedo
Journal:  Int J Geriatr Psychiatry       Date:  2004-03       Impact factor: 3.485

View more
  3 in total

1.  Developing a Spatial Navigation Screening Tool Sensitive to the Preclinical Alzheimer Disease Continuum.

Authors:  Samantha L Allison; Thomas L Rodebaugh; Chiharu Johnston; Anne M Fagan; John C Morris; Denise Head
Journal:  Arch Clin Neuropsychol       Date:  2019-10-24       Impact factor: 2.813

Review 2.  Cognitive Functioning of Unaffected First-degree Relatives of Individuals With Late-onset Alzheimer's Disease: A Systematic Literature Review and Meta-analysis.

Authors:  Ari Alex Ramos; Noelia Galiano-Castillo; Liana Machado
Journal:  Neuropsychol Rev       Date:  2022-09-03       Impact factor: 6.940

3.  Developmental changes in episodic memory across early- to mid-childhood: insights from a latent longitudinal approach.

Authors:  Kelsey L Canada; Gregory R Hancock; Tracy Riggins
Journal:  Memory       Date:  2021-11-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.